HOME >> BIOLOGY >> NEWS
DNA test solving Chesapeake's toxic mysteries

As the summer heats up Chesapeake Bay waters, a new kind of test to detect toxic marine microbes is sharpening Maryland efforts to predict fish-killing Pfiesteria. The test also helps medical studies of illness associated with the microbe.

David Oldach of the University of Maryland Biotechnology Institute (UMBI) reports that the test, applied to samples of mud or water, rapidly identifies Pfiesteria piscicida. In 1997, the microbe was linked with major fish kills in three Maryland rivers as well as previous fish kills in North Carolina. In addition, watermen near the fish kills and laboratory workers handling Pfiesteria cultures have suffered from illness ranging from skin lesions and stomach cramps to temporary memory loss and learning impairment lasting up to seven weeks.

In a recent issue of the Proceedings of the National Academy of Sciences, Oldach writes that the test is based on a "time-tested molecular biology method used commonly in medical research." The method, called HMA, is more often used to tease ut different strains of viruses in studies of Hepatitis C, AIDS, or gene mutations linked with cancer, or genetic diseases, such as cystic fibrosis.

Oldach and colleagues at UMBI's Institute of Human Virology (IHV) applied the method to samples of water and cultures of Pfiesteria-like microbes from Maine, Maryland, and North Carolina. The result is a DNA fingerprint of Pfiesteria used in the new test. The test can be adapted to detect other toxic marine organisms, he adds.

Last year in Maryland, experiments on the new test helped show that P. piscicida existed in at least 14 rivers and increased dramatically in July and August, according to Dave Goshorn, chief of the Maryland Department of Natural Resources' (DNR) Living Resource Assessment Program. "We found that the new test works so well, we will expand from 50 to 100 testing sites in the Bay area in 2000, in addition to any fish kill sites."

The new Pfiesteria test i
'"/>

Contact: Steve Berberich
berberic@umbi.umd.edu
410-385-6315
University of Maryland Biotechnology Institute
30-Jul-2000


Page: 1 2 3

Related biology news :

1. Carnegie Mellon scientists reveal ways of studying, resolving PCB contamination in US rivers
2. Imaging the brain solving problems through insight
3. Saint Louis University researchers make breakthrough towards solving the cause of cancer development
4. Chemistry to play major role in solving 21st century challenges
5. Resolving Conflicts -- What We Can Learn From The Apes
6. Rice finds on-off switch for buckyball toxicity
7. Prion propagation: Avoiding the toxic oligomer
8. Byproduct of water-disinfection process found to be highly toxic
9. Stem cells more vulnerable to toxic chemotherapy when protective molecule is disabled
10. Sediments in many Central Valley streams contain toxic levels of pyrethroid pesticides
11. JGI decodes wood & toxic waste-degrading fungus genome

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... Andrew D Zelenetz ... Published recently in Oncology ... touchONCOLOGY, Andrew D Zelenetz , discusses the ... is placing an increasing burden on healthcare systems ... With the patents on many biologics expiring, interest ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
Breaking Biology Technology:
Cached News: